首页> 美国卫生研究院文献>Saudi Pharmaceutical Journal : SPJ >Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol
【2h】

Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol

机译:酮洛芬与PVP K30和d-甘露醇的固体分散体的理化特性和体外溶出研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aim of the present study was to improve the solubility and dissolution rate of poorly water soluble, BCS class-II drug Ketoprofen (KETO) by solid-dispersion approach. Solid dispersions were prepared by using polyvinylpyrrolidone K30 (PVP K30) and d-mannitol in different drugs to carrier ratios. Dispersions with PVP K30 were prepared by kneading and solvent evaporation techniques, whereas solid dispersions containing d-mannitol were prepared by kneading and melting techniques. These formulations were characterized in the liquid state by phase-solubility studies and in the solid state by Differential Scanning Calorimetry (DSC), Fourier Transform Infrared (FTIR) spectroscopy, X-ray diffraction (XRD) and Scanning Electron Microscopy (SEM). The aqueous solubility of KETO was favored by the presence of both carriers. The negative values of Gibbs free energy illustrate the spontaneous transfer from pure water to the aqueous polymer environment. Solid state characterization indicated KETO was present as fine particles in d-mannitol solid dispersions and entrapped in carrier matrix of PVP K30 solid dispersions. In contrast to the very slow dissolution rate of pure KETO, dispersions of drug in carriers considerably improved the dissolution rate. This can be attributed to increased wettability and dispersibility, as well as decreased crystallinity and increase in amorphous fraction of drug. Solid dispersions prepared with PVP K30 showed the highest improvement in dissolution rate of KETO. Even physical mixtures of KETO prepared with both carriers also showed better dissolution profiles than those of pure KETO.
机译:本研究的目的是通过固体分散法改善水溶性差的BCS II类药物酮洛芬(KETO)的溶解度和溶解速率。通过使用聚乙烯吡咯烷酮K30(PVP K30)和d-甘露糖醇以不同的药物与载体比例制备固体分散体。通过捏合和溶剂蒸发技术制备含PVP K30的分散体,而通过捏合和熔融技术制备含d-甘露醇的固体分散体。这些制剂在液相中通过相溶解度研究进行表征,在固态中通过差示扫描量热法(DSC),傅立叶变换红外(FTIR)光谱,X射线衍射(XRD)和扫描电子显微镜(SEM)进行表征。两种载体的存在有利于KETO的水溶性。吉布斯自由能的负值说明了从纯水到水性聚合物环境的自发转移。固态表征表明,KETO以细颗粒形式存在于d-甘露醇固体分散体中,并被困在PVP K30固体分散体的载体基质中。与纯KETO的溶解速度非常慢相反,药物在载体中的分散大大改善了溶解速度。这可以归因于增加的润湿性和分散性,以及降低的结晶度和药物无定形部分的增加。用PVP K30制备的固体分散体显示出KETO溶解速率的最高改善。甚至与两种载体一起制备的KETO物理混合物也显示出比纯KETO更好的溶出曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号